Announce your event here
First Nordic Conference on personalized medicine.
2018-05-30 to 2018-06-01
Nyborg, Denmark.

We would like to welcome you to First Nordic conference on personalized medicine. This will take place from: May 30th – June 1st 2018 at Hotel Nyborg Strand in Nyborg, Denmark.

Nyborg is located on the coast of Funen with beaches towards the Great Belt (Storebælt). Transport from Copenhagen airport is convenient with trains departing approximately every hour.

This 3-day conference will focus on both basic and clinical aspects of research regarding personalized medicine. The program will consist of talks and workshops within pharmacogenetics, drug interactions, epigenetics and other factors that may cause variation in drug response among individuals. Furthermore, there will be focus on methods available across the participating researchers.

This conference will be an excellent opportunity to network with colleagues and possibly establish international collaborations.

More information will be made available on this website as the planning progresses.

We look forward to seeing you,


Tore Bjerregaard Stage & Kim Brøsen link

2nd Annual Precision Medicine Congress
2018-06-11 to 2018-06-12
Munich, Germany

Join Oxford Global for the 2nd Annual Precision Medicine Congress, 11-12 June 2018, Munich as our panel of over 40 world class speakers discuss the latest regulatory updates, biomarker developments, information technologies and companion diagnostics for personalized therapies.        

View Agenda:

Across two days, our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. Over 40 presentations and case studies focusing on the key developments in precision medicine regulation, biomarkers, clinical development, digital technologies and diagnostics.

4 interactive streams:

2018 Live Webinar:

Precision Medicine & Cancer Genomics – Clinical And Pharmaceutical Applications
Hosted by Dr Honey Reddi, The Jackson Laboratory and Dr Michael Menden, AstraZeneca.
Register for Free Now:

2017 Free Webinar Recording:

Clinical Utility of Genomic Testing 
Hosted by Elaine Lyon, Professor, University of Utah & Medical Director of Molecular Genetics, ARUP Laboratories.
Download for Free:

For further information regarding prices and possible discounts, please contact Guillaume Alonso on or call +44 (0)1865 248 455. link

Personalized and Precision Medicine International Conference – PEMED 2018
2018-06-25 to 2018-06-27
Whether you are interested in diagnostics, bioinformatics, drug discovery, and therapies, with the aim of translating precision medicine into direct improvements in health care, PEMED 2018 is the place to be, to meet, discuss and eventually do business in this exciting new space.
Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, etc.)
Biomarkers and diagnostics, liquid biopsy, imaging, biochip/microarray technologies, advancements in technologies
Drug target discovery and integration with individualized therapy, integration of diagnosis with therapy (theragnosis)
Integrating Big Data (genome data, pharmacogenomics, therapeutic applications of genome editing, genetic analysis in clinical trials methodology, etc.)
Emerging opportunities in personalized medicine, cutting-edge new strategies and solutions
Cost-benefit issues, and ethics in precision medicine
Plenary Speakers:
Prof. Jacques Beckmann - University of Lausanne, Switzerland
Prof. Anna Dominiczak - University of Glasgow, UK
Prof. Klaus Pantel - Center for Experimental Medicine, Germany
Prof. Anne-Marie Caminade - Coordination Chemistry Lab of Toulouse and University of Toulouse, France
Prof. Fabrice André - Gustave Roussy Institute, France
Prof. Yosef Yarden - Weizmann Institute of Science, Israel
Prof. Richard Weinshilboum - Mayo Clinic, USA
Prof. Matthias Schwab - IKP Stuttgart and University Hospital Tuebingen, Germany
Prof. Xiangyang Shi - Donghua University, China
Prof. Søren Brunak - Technical University of Denmark
Prof. Manuel Perucho - Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Spain
Dr. Philip Murphy - National Institute of Allergy and Infectious Diseases, USA link

RNA Therapeutics: From Base Pairs to Bedsides
2018-06-28 to 2018-06-29
Worcester, MA, USA
We live in an exciting time for the RNA research community. Throughout the latter half of the 20th century, we believed that RNA’s primary role was to intermediate between DNA and protein. Over the last three decades, those long-held beliefs have been shattered. From ncRNAs to RNAi, from CRISPR to circular RNAs, we have witnessed astonishing discoveries and equally amazing translation of these breakthroughs to therapy. Come and join the discussion as we explore the era of RNA therapeutics. link

The 9th Santorini Conference
2018-09-30 to 2018-10-03
Santorini, Greece

The goal of The 9th Santorini Conference is to gather all together Academics researchers, pharmaceutical and biotechnological companies, specialists in laboratory medicine, pharmacologists, clinicians, geneticists, pharmacists from hospital and epidemiologists to discuss: How the way of the variability in the human genome, in the expressed protein and in the circulatory metabolites can be useful and used for:



The 9th Conference aims to answer:


The scientific program includes 9 sessions, 1 young scientist session, 2 scientifical meetings with leaders in European program important for personalised medicine and 1 round table on the future of precision medicine.


To submit your abstract or register please go on at: link

3rd Annual Biomarkers & Precision Medicine USA Congress
2018-10-11 to 2018-10-12
San Diego, USA

The 3rd Annual Biomarkers & Precision Medicine USA Congress is part of Oxford Global’s R&D US Series that features 3 outstanding programmes: our long-running 5th Annual Drug Discovery and Chemistry USA Congress, the 3rd Annual Biomarker & Precision Medicine USA Congress, and fast-emerging Advances in Immuno-Oncology USA Congress.

This event will host over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

4 Interactive Streams:

Free Pre-Congress Live Webinars 2018


Moving Diagnostic Biomarkers from Bench into the Clinic
Hosted by James Snider, CSO and President, Critical Diagnostics & Elizabeth Somers, Director Diagnostics, Morphotek

Register today, for free:

Moving Biomarkers from Bench into the Clinic
Hosted by Xuemei Zhao, Senior Principal Scientist, Merck & Co., Inc  & Qing Kang, Senior Scientist, Translational Medicine at Syros Pharmaceuticals

Register today, for free:

Driving Precision Medicine and Advancing Big Data in Drug Development
Hosted by Stefan Scherer, Vice President, Global Head Correlative Science, Novartis

Register today, for free:


For further information about the congress, registration fees and discounts available please contact or click here:

Alternatively visit our website link

Advances in Immuno-Oncology USA Congress
2018-10-11 to 2018-10-12
San Diego, USA

Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.


Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.


Further talks look at approaches to clinical trial design and development and Translational Immuno-Oncology. To enhance the interactivity of the program, we have also introduced discussion opportunities through panels, roundtables and workshops on hot topics in this field.


Key speakers include Vice Presidents, Directors and Executives from leading pharmaceutical industries such as Pfizer and Atreca. The two day congress offers the opportunity to have scientific and business discussions, ensuring valuable networking and interactive sessions.


The conference will bring together over 100 senior industry experts and key opinion leaders in Immuno-Oncology.


For further information about the congress, please contact Danielle Dalby at alternatively download the agenda here >>




Free Pre-Congress Live Webinar


The Role For TNFR2 In The Tumor Microenvironment

Hosted by Russell LaMontagne, Chief Executive Officer, Boston Immune Technologies and Therapeutics Inc


Why should you attend this webinar?

Register for free today >> link

4th Annual Genome Editing Congress
2018-11-08 to 2019-11-09
London, UK

Oxford Global are proud to present our hugely popular 4th Annual Genome Editing Congress, 8th – 9th May 2018, London, UK. Over 600 senior level delegates will be in attendance representing internationally renowned research & academic institutions, clinical research institutions, nutrition companies as well as a leading pharmaceutical and biotech companies.

Including 2 interactive streams:

Co-located with the 10th Annual Next Generation Sequencing and Clinical Diagnostics Congress, 6th Annual Single Cell Analysis Congress and also the brand new Synthetic Biology Congress.

View the Agenda here:

For further information, prices & discounts please contact

www.genomeediting-congress.comexternal link